Details
| Stereochemistry | RACEMIC |
| Molecular Formula | C25H35NO4 |
| Molecular Weight | 413.5497 |
| Optical Activity | ( + / - ) |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CCC(C)(C)NCC(O)COC1=C(OC)C=CC(CCC(=O)C2=CC=C(C)C=C2)=C1
InChI
InChIKey=WUUQBRHWNUFEEB-UHFFFAOYSA-N
InChI=1S/C25H35NO4/c1-6-25(3,4)26-16-21(27)17-30-24-15-19(10-14-23(24)29-5)9-13-22(28)20-11-7-18(2)8-12-20/h7-8,10-12,14-15,21,26-27H,6,9,13,16-17H2,1-5H3
| Molecular Formula | C25H35NO4 |
| Molecular Weight | 413.5497 |
| Charge | 0 |
| Count |
|
| Stereochemistry | RACEMIC |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 1 |
| E/Z Centers | 0 |
| Optical Activity | ( + / - ) |
Alprafenone [AH 141], a phenylpropanone derivative, is presently classified as a class Ic antiarrhythmic agent, it is a sodium channel antagonist. Alprafenone's range of actions is consistent with that of other effective antiarrhythmic drugs and is very similar to that of propafenone. Alprafenone was under preclinical development with Helopharm (Germany), but later this development was discontinued.
Originator
Approval Year
Sample Use Guides
In canine Purkinje fibers (PF) with normal maximum diastolic potentials (MDPs), alprafenone (5 x 10(-8)-1 x 10(-6) M) produced concentration-dependent decreases in AP amplitude (APA), Vmax, AP duration (APD), and conduction velocity. Alprafenone produced a reduction in contraction amplitude of rat electrically stimulated myocytes with a similar dose-response relationship (IC50 approx. 10 umol/l).
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:31:46 GMT 2025
by
admin
on
Mon Mar 31 18:31:46 GMT 2025
|
| Record UNII |
D5H25D039V
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Official Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C47793
Created by
admin on Mon Mar 31 18:31:46 GMT 2025 , Edited by admin on Mon Mar 31 18:31:46 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
6509
Created by
admin on Mon Mar 31 18:31:46 GMT 2025 , Edited by admin on Mon Mar 31 18:31:46 GMT 2025
|
PRIMARY | |||
|
CHEMBL2104075
Created by
admin on Mon Mar 31 18:31:46 GMT 2025 , Edited by admin on Mon Mar 31 18:31:46 GMT 2025
|
PRIMARY | |||
|
C076009
Created by
admin on Mon Mar 31 18:31:46 GMT 2025 , Edited by admin on Mon Mar 31 18:31:46 GMT 2025
|
PRIMARY | |||
|
SUB05369MIG
Created by
admin on Mon Mar 31 18:31:46 GMT 2025 , Edited by admin on Mon Mar 31 18:31:46 GMT 2025
|
PRIMARY | |||
|
C72572
Created by
admin on Mon Mar 31 18:31:46 GMT 2025 , Edited by admin on Mon Mar 31 18:31:46 GMT 2025
|
PRIMARY | |||
|
124316-02-5
Created by
admin on Mon Mar 31 18:31:46 GMT 2025 , Edited by admin on Mon Mar 31 18:31:46 GMT 2025
|
PRIMARY | |||
|
65951
Created by
admin on Mon Mar 31 18:31:46 GMT 2025 , Edited by admin on Mon Mar 31 18:31:46 GMT 2025
|
PRIMARY | |||
|
100000087452
Created by
admin on Mon Mar 31 18:31:46 GMT 2025 , Edited by admin on Mon Mar 31 18:31:46 GMT 2025
|
PRIMARY | |||
|
DTXSID80869697
Created by
admin on Mon Mar 31 18:31:46 GMT 2025 , Edited by admin on Mon Mar 31 18:31:46 GMT 2025
|
PRIMARY | |||
|
D5H25D039V
Created by
admin on Mon Mar 31 18:31:46 GMT 2025 , Edited by admin on Mon Mar 31 18:31:46 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ENANTIOMER -> RACEMATE | |||
|
|
ENANTIOMER -> RACEMATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |